Delivery Order SPE2DB22D3004-SPE2DB25FSF32
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,888.28 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The order is scheduled for completion by July 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy...
- The Defense Logistics Agency awarded a delivery order valued at $2,919.85 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $16,140.89. This delivery order represents a firm fixed price contract with no set-aside designation, utilizing open and competitive procurement practices. The contract is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,262.72 and an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- The Defense Logistics Agency awarded a $40,852.26 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of July 24, 2025, with performance to take place at the vendor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used primarily in the treatment of chronic hepatitis B, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $134,109.38 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract calls for performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, valued at $4,584.29. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, issued under a competitive procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSF32Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,880.31 to AmerisourceBergen Drug Corp for 30-tablet units of Vemlidy 25 mg tablets on August 28, 2025, with completion expected by August 29, 2025. This is a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy (tenofovir alafenamide) is an antiviral medication used in the treatment of chronic hepatitis B, reflecting the Defense Logistics Agency's responsibility for supplying critical pharmaceutical products to military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. That prime contract vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills individual delivery orders under this umbrella contract for specific pharmaceutical products needed across the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/28/25 |